O. U. Ozcan Et Al. , "Metabolic syndrome is a risk factor for contrast-induced nephropathy after percutaneous coronary intervention," Annual Meeting of the European-Society-of-Cardiology (ESC) , vol.35, Barcelona, Spain, pp.1071, 2014
Ozcan, O. U. Et Al. 2014. Metabolic syndrome is a risk factor for contrast-induced nephropathy after percutaneous coronary intervention. Annual Meeting of the European-Society-of-Cardiology (ESC) , (Barcelona, Spain), 1071.
Ozcan, O. U., Er, H. A., Gulec, S., TULUNAY KAYA, C., Akbulut, I. M., Baris, V. O., ... Atmaca, Y.(2014). Metabolic syndrome is a risk factor for contrast-induced nephropathy after percutaneous coronary intervention . Annual Meeting of the European-Society-of-Cardiology (ESC) (pp.1071). Barcelona, Spain
Ozcan, O. Et Al. "Metabolic syndrome is a risk factor for contrast-induced nephropathy after percutaneous coronary intervention," Annual Meeting of the European-Society-of-Cardiology (ESC), Barcelona, Spain, 2014
Ozcan, O. U. Et Al. "Metabolic syndrome is a risk factor for contrast-induced nephropathy after percutaneous coronary intervention." Annual Meeting of the European-Society-of-Cardiology (ESC) , Barcelona, Spain, pp.1071, 2014
Ozcan, O. U. Et Al. (2014) . "Metabolic syndrome is a risk factor for contrast-induced nephropathy after percutaneous coronary intervention." Annual Meeting of the European-Society-of-Cardiology (ESC) , Barcelona, Spain, p.1071.
@conferencepaper{conferencepaper, author={O. U. Ozcan Et Al. }, title={Metabolic syndrome is a risk factor for contrast-induced nephropathy after percutaneous coronary intervention}, congress name={Annual Meeting of the European-Society-of-Cardiology (ESC)}, city={Barcelona}, country={Spain}, year={2014}, pages={1071} }